Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
AbbVie is accused of paying kickbacks, using a stealthy network of nurses to promote Humira
California Sues AbbVie Over Alleged Arthritis Drug Kickbacks
High drug prices: America’s migraine (and how to fix it)
‘Mentorship is a Conversation for Life’ Says the Mentor of This Social Entrepreneur
Submission to FTC on the Role of Intellectual Property
A Chinese twist in the tale involving Hepatitis C drug Sofosbuvir
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Would reforming the U.S. patent system help to lower drug prices?
China Patent Challenge Compels Gilead to Withdraw Key Patent Claims on Sofosbuvir Base Compound, Opening Life-Saving Hepatitis C Treatment Access for Millions
Reality check on PBMs and drug costs